Last updated on: 24 Mar 2026, 5:57 PM

Speciality Medicines Limited IPO

BSE SME

₹ 248000 /2000 Shares
Minimum Investment

Speciality Medicines Limited IPO subscription status: 2.33 times on (24 Mar 2026, 5:57 PM); QIB 96.24x, NII 2.01x, and Individual 0.85x.

Subscription Details (No. of Shares)

Category Offer Applied Times
QIBs 21000 2021000 96.24
NIIs 1089000 2194000 2.01
BNIIs (>10L) 726000 1963000 2.7
SNIIs (<10L) 363000 231000 0.64
Individual 1090000 922000 0.85
Total 2200000 5137000 2.33
Total Applications685 apprx

Application Wise Breakup (Approx.)

Category Reserve Applied Times
BNIIs (>10L) 242 167 0.69
SNIIs (<10L) 121 55 0.45
Individual 545 461 0.85
Total Applications685 apprx

Subscription Details (In Crores)

Category Offered Demand Times
QIBs 0.26 25.06 96.24
FIIs - 25.06 -
DIIs - 0.00 -
Mutual Funds - 0.00 -
Others - 0.00 -
NIIs 13.5 27.21 2.01
BNIIs (>10L) 9 24.34 2.7
SNIIs (<10L) 4.5 2.86 0.64
Individual 13.52 11.43 0.85
TOTAL 27.28 63.7 2.33
Important Disclaimer

Data Source: The above information / data is sourced from National Stock Exchange (NSE) and Bombay Stock Exchange (BSE) websites and is subject to change in real time. For latest information / data, please refer to the respective websites.

Purpose: The information / data provided herein is for informational purposes only and is provided by ipoji.com on "AS IS" and "AS AVAILABLE" basis and without warranty, express or implied.

Accuracy: ipoji.com does not warrant the accuracy, adequacy or completeness of the information you obtain through the above websites.

Liability: ipoji.com shall not be liable in any way for any discrepancies, errors, omissions, losses or damage. ipoji.com, including its affiliates and its directors, staff and employees, shall not be liable for any loss, damage of any kind, including but not limited to direct, indirect, punitive, exemplary, consequential damages and lost profits arising in any way out of the use of information / data obtained through the said websites.

User Responsibility: The recipient alone is fully responsible / liable for any decision made based on this information / data. All recipients, before relying on the said information, should do their own research and seek appropriate professional advice.